UTILISATION OF VIDEO CALLS TO IMPROVE ADHERENCE IN TUBERCULOSIS PATIENTS: PILOT STUDY
DOI:
https://doi.org/10.32734/idjpcr.v8i01.20557Keywords:
Adherence, Tuberculosis, Video callsAbstract
Tuberculosis is the 9th leading cause of death in the world, but it takes at least 6 months to be treated. One of the challenges in tuberculosis treatment is that the treatment time is quite long, and the drugs used are also quite a lot so that it affects patient adherence in taking medication. The objective of this study was to see the effectiveness of video calls in enhancing the adherence of tuberculosis patients. The research method used was experimental pre-post noncontrol design. This study involved 12 tuberculosis patients from the Kepulungan Community Health Centre who were enrolled in the Pulmonary Tuberculosis Control Programme (Program Penanggulangan Tuberkulosis Paru/P2TB) and who met the study's inclusion and exclusion criteria. In the study, video call treatment was the independent variable while adherence was the dependent variable. The sample collection used total sampling and statistical analysis using Wilcoxon test. The findings of this investigation suggest that there is a substantial discrepancy in compliance levels between the pre- and post-video call treatment phases, as evidenced by the augmentation in the mean TB-MAS score from 102.5 to 113.6, accompanied by a p-value of 0.018 (<0.05). This shows that video calls are useful in improving patient adherence in taking antituberculosis drugs.
Downloads
References
Kementerian Kesehatan Republik Indonesia. Keputusan Menteri RI tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Jakarta: Kemenkes RI; 2019. p. 1–139.
World Health Organization. Global Tuberculosis Report 2020 [Internet]. Geneva: World Health Organization; 2020 [cited 2025 Jul 7]. Available from: https://www.who.int/publications/i/item/9789240013131
Dinas Kesehatan Provinsi Jawa Timur. Profil Kesehatan Provinsi Jawa Timur Tahun 2019. Surabaya: Dinkes Provinsi Jawa Timur; 2020. Tabel 53.
Bediang G, Stoll B, Elia N, Abena JL, Geissbuhler A. SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): A randomized controlled trial. BMC Public Health. 2018;18(1):583. doi:10.1186/s12889-018-5490-4
Sekandi JN, Buregyeya E, Zalwango S, Dobbin KK, Atuyambe L, Nakkonde D, et al. Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: A pilot cohort study. ERJ Open Res. 2020;6(1):00175-2019. doi:10.1183/23120541.00175-2019
Pampalia N, Waluyo A. Mhealth untuk kepatuhan pasien TB dalam pengobatan: Sebuah tinjauan literatur. J Wacana Kesehat. 2019;4(1):404–10.
Yin X, Tu X, Tong Y. Development and validation of tuberculosis medication adherence scale. Patient Prefer Adherence. 2012;6:427–34. doi:10.2147/PPA.S34833
Sikumbang RH, Eyanoer PC, Siregar NP. Faktor-faktor yang berhubungan dengan kejadian TB paru pada usia produktif di wilayah kerja Puskesmas Tegal Sari Kecamatan Medan Denai. Ibnu Sina J Kedokt dan Kesehat. 2022;21(1):32–43.
Dotulong JFJ, Sapulete MR, Kandou GD. Hubungan faktor risiko umur, jenis kelamin, dan kepadatan hunian dengan kejadian penyakit TB paru di Desa Wori Kecamatan Wori. J Kedokt Komunitas dan Trop. 2015;3(2):57–65.
Nopita E, Suryani L, Siringoringo HE. Analisis kejadian tuberkulosis (TB) paru. J Kesehat Glob. 2023;6(1):50–6.
Pranda V, Andatani N. Hubungan tingkat pendidikan terhadap angka kejadian multidrugs resistant tuberculosis (MDR-TB) di RSUDZA Banda Aceh. J Penelit Nanggroe Med. 2018;1(4):7–13.
Puskesmas Kepulungan. Laporan Kegiatan Program Penanggulangan Tuberkulosis Paru (P2TB) Tahun 2023. Pasuruan: Puskesmas Kepulungan; 2023.
Puskesmas Kepulungan. Standar Operasional Prosedur (SOP) Pemantauan Pasien TB Melalui Video Call (WhatsApp). Pasuruan: Puskesmas Kepulungan; 2023.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indonesian Journal of Pharmaceutical and Clinical Research

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Indonesian Journal of Pharmaceutical and Clinical Research (IDJPCR) and Faculty of Pharmacy as well as TALENTA Publisher Universitas Sumatera Utara as publisher of the journal.
Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from Indonesian Journal of Pharmaceutical and Clinical Research (IDJPCR).
The Copyright Transfer Form can be downloaded here.
The copyright form should be signed originally and sent to the Editorial Office in the form of original mail or scanned document.